|
23 June 2007, Saturday - Arrival, Opening Reception
24 June 2007, Sunday - Main Program (Day 1)
25 June 2007, Monday - Main Program (Day 2)
26 June 2007, Tuesday - Main Program (Day 3)
27 June 2007, Wednesday - Main Program (Day 4)
28 June 2007, Thursday - Main Program (Day 5)
29 June 2007, Friday - Main Program (Day 6)
& Departure
SATURDAY 23 June
2007
Arrival, Opening Reception
| Time |
Topic |
Location |
| |
Arrival |
|
![]() |
| 12:00 - 16:00 |
Registration |
PALEXCO
Main Foyer |
![]() |
![]() |
| 19:00 - 22:00 |
Opening Reception
Choral Music Recital |
University's Aula Magna
University Chapel |
![]() |
SUNDAY 24
JUNE 2007 (Day 1)
| Time |
Topic |
Speaker |
| 08:00 - 08:15 |
Welcome, Opening
Remarks |
Kim Solez
Lorraine Racusen |
![]() |
| |
Plenary Session |
|
| 08:15 - 08:45 |
Organ donation
success. |
Rafael Matesanz* |
| 08:45 - 09:15 |
The Banff 05
meeting report – fibrosis in the renal allograft. |
Kim Solez* |
![]() |
|
09:15 - 09:45 |
Break |
|
![]() |
| |
Peritubular
Capillaries & C4d |
Robert B. Colvin
Mark Haas |
| 09:45--10:00 |
Liver C4d Studies. |
Chris Bellamy* |
| 10:00 - 10:15 |
C4d deposition and capillaritis grading after 3
months post-transplant.
Update on
C3d staining. |
Evelyne Lerut* |
| 10:15 - 10:30 |
Scoring system for peritubular
capillary margination, reproducibility studies
and clinical correlates. |
Ian Gibson*
Michael Mengel* |
| 10:30 - 10:45 |
Effects of antibody and complement on endothelium
in vitro. |
Heinz Regele* |
| 10:45 - 11:00 |
Expression of complement inhibitors as a possible
marker/mechanism for graft accommodation to
anti-donor antibodies. |
Rene Rodriguez* |
| 11:00 - 11:15 |
Comparison of methods for C4d
staining. |
Michael Mihatsch* |
| 11:15 - 11:30 |
Recommendations for scoring and reporting focal
C4d in kidneys. |
Michael Mengel* |
| 11:30 - 12:00 |
Discussion |
|
![]() |
| 12:00 - 13:00 |
Lunch |
|
![]() |
| |
EMT, MET & Allografts
Symposium |
Roslyn B. Mannon
Lorraine Racusen |
| 13:00-13:20 |
Epithelial-mesenchymal transformation – new
insights. |
Michael Zeisberg* |
| 13:20-13:40 |
Biomarkers, mediators, and mechanisms. |
Roslyn B. Mannon* |
| 13:40-14:00 |
Allograft fibrosis: intraepithelial signaling. |
Helen Robertson* |
| 14:00-14:20 |
Immunolocalization of fibroblast factors in
inflammatory renal disease. |
Agnes Fogo* |
| 14:20-14:40 |
EMT and the role of tubular cells. |
Attapong Vongwiwatana* |
![]() |
|
14:40 - 15:00 |
Break |
|
![]() |
|
15:00-15:20 |
Ischemia, immunologic injury and EMT. |
Alexandre Hertig*
Denis Glotz |
|
15:20-15:40 |
EMT and oxidative stress. |
Arjang Djamali* |
|
15:40-16:00 |
The epithelial cell as a target
site of injury: mechanisms and potential
interventions. |
John Kirby* |
|
16:00-16:20 |
Polyoma virus, tubular epithelial cells, and EMT. |
Roslyn B. Mannon* |
|
16:20-16:40 |
Monocyte/endothelial cell reaction – impact on
epithelial cells, with remarks on primate models
of rejection. |
Allan Kirk* |
![]() |
|
16:40 - 17:00 |
Break |
|
![]() |
|
17:00-18:00 |
Report of Transcriptome Satellite. |
Philip F. Halloran* |
![]() |
MONDAY 25 JUNE
2007 (Day 2)
|
Time |
Topic |
Speaker |
| |
Heart
Symposium |
E. Rene Rodriguez
Maria G. Crespo-Leiro |
| 08:00 - 08:10 |
Introduction |
E. Rene Rodiguez* |
| 08:10 - 08:30 |
The revised ISHLT working
formulation of heart transplant pathology. |
Susan Stewart* |
| 08:30 - 08:50 |
Pediatric heart
transplantation, cellular rejection, antibody
mediated rejection and allograft vasculopathy. |
Nancy Bridges* |
| 08:50 -09:10 |
Allograft dysfunction with
“negative pathology”: What to do? |
Mario Deng* |
| 09:10 - 09:30 |
Non HLA antigens as targets for
antibody mediated rejection in heart
transplants. |
Elaine F Reed* |
| 09:30 - 10:00 |
Molecular testing and
prediction of rejection in cardiac
transplantation. |
Mario Deng* |
![]() |
| 10:00 - 10:30 |
Break |
|
![]() |
| 10:30 - 10:45 |
Diagnostic criteria for
antibody mediated rejection. |
E. Rene Rodiguez* |
| 10:45 - 11:00 |
Antibodies and complement in
allograft vasculopathy. |
William M. Baldwin* |
| 11:00 - 11:20 |
Antibody mediated rejection and
allograft vasculopathy: Evidence of modulation
by different immunosuppressive therapy schemas. |
Juan Delgado* |
| 11:20 - 12:00 |
Discussion |
|
![]() |
| 12:00 - 13:00 |
Lunch |
|
![]() |
| |
Pancreas Symposium |
Cinthia Drachenberg |
| 13:00 - 13:30 |
Role of protocol
biopsies in pancreas transplantation. |
Samy Iskandar* |
| 13:30 - 14:00 |
Antibody
mediated rejection in pancreas allografts. |
John
Papadimitriou* |
| 14:00 - 14:30 |
Pathological
diagnosis of acute rejection in the pancreas: A
surgeon's perspective. |
Jon Odorico* |
![]() |
| 14:30 - 15:00 |
Break |
|
![]() |
| 15:00 - 15:30 |
Recurrence of Type 1 Diabetes in pancreas
transplantation. |
Philllip Ruiz* |
| 15:30 - 17:00 |
Consensus
discussion: Finalization of a grading
scheme for acute allograft rejection in the
pancreas. |
|
![]() |
|
19:00 - 21:00 |
City Hall
Reception |
|
|
2100 - 23:00 |
Musical
Evening (Philharmonic Orchestra) |
|
![]() |
TUESDAY 26
JUNE 2007 (Day 3)
| Time |
Topic |
Speaker |
| |
T-Regulatory
Cells
Symposium |
Robert B. Colvin
Lorraine Racusen |
|
08:00- 08:20 |
T-regulatory cells and tolerance: Mechanisms of
suppressive function. |
Luis Graca* |
|
08:20- 08:40 |
T-regulatory cells and monitoring of tolerance. |
Maria Manuela Carvalho-Gaspar* |
|
08:40-09:00 |
Transcription factors and T-regulatory
function. |
Stanislow Stepkowski* |
|
09:00-09:20 |
Expanding
T-regulatory cells in vitro and in
vivo for tolerance induction to allografts. |
Haval Shirwan* |
|
09:20-09:40 |
Adoptive cell therapy with T-regulatory cells. |
Robert Lechler* |
|
09:40 - 10:00 |
Gene expression data on Foxp3 in
clinical biopsies. |
Josep M. Grinyó* |
![]() |
| 10:00 - 10:20 |
Break |
|
![]() |
| 10:20-10:40 |
T-regulatory cells in ischemic
injury. |
Alvaro Pacheco-Silva* |
|
10:40-11:00 |
T-regulatory cells in Campath-treated patients. |
Debra Bloom* |
|
11:00-11:20 |
T-regulatory cells in human graft biopsies –
correlations. |
Robert B. Colvin* |
|
11:20-11:40 |
T-regulatory cells in stable renal transplants. |
Manuel Arias*
Marcos Lopez-Hoyos
|
|
11:40-12:00 |
T-regulatory cells – role in kidney allograft
fibrosis. |
John Kirby* |
![]() |
| 12:00 - 13:00 |
Lunch |
|
![]() |
|
|
Composite Tissue Grafts Symposium |
Linda Cendales |
|
13:00-13:20 |
History of composite tissue transplantation.
|
Charles W. Hewitt*
Kirby Black |
|
13:20-13:40 |
Hand transplantation pathology: The Belgium experience. |
Myriam Remmelink* |
|
13:40-14:00 |
Histopathological update on Spanish hand
transplant experience. |
Luis Landín* |
|
14:00-14:20 |
Pathologic entities that could mimic skin
rejection. |
Jean Kanitakis* |
![]() |
|
14:20-14:40 |
Break |
|
![]() |
|
14:40-15:00 |
Composite tissue allograft rejection: A Louisville perspective. |
Carolyn Burns* |
|
15:00-15:20 |
Histopathology of rejection in abdominal wall
allotransplantation. |
Phillip Ruiz* |
|
15:20- 15:40 |
Histopathology of skin rejection: The Austrian
experience. |
Stefan Schneeberger* |
|
15:40-16:00 |
Development of grading systems for CTA rejection:
proposals and prospects. |
David Kleiner* |
![]() |
| 16:00-17:30 |
Consensus Discussions:
Composite Tissue Grafts |
Linda Cendales* |
![]() |
|
17:30 - 19:30 |
Poster Presentations with Wine & Cheese |
|
![]() |
WEDNESDAY
27 JUNE 2007 (Day 4)
| Time |
Topic |
Speaker |
|
|
Mechanisms of Rejection Symposium |
Philip F. Halloran |
|
08:00 - 08:30 |
Lessons from the epithelium. |
Gunilla Einecke* |
|
08:30 - 09:00 |
C4 staining in mouse kidney
transplants: Mechanisms and insights. |
Banu Sis* |
|
09:00 - 09:30 |
The IFN gamma response and its
significance. |
Philip F. Halloran* |
|
09:30 - 10:00 |
Chemokines and cell populations in
experimental transplantation. |
Robert Fairchild* |
![]() |
|
10:00 - 10:30 |
Break |
|
![]() |
|
10:30 - 11:00 |
Emerging molecular signatures of
T-cell mediated rejection and antibody-mediated
rejection. |
Philip F. Halloran* |
|
11:00 - 11:30 |
Mechanisms of graft rejection:
Insights from primate studies. |
Neal Smith* |
|
11:30 -12:00 |
The implications of somatic cell senescence in transplantation. |
Anette Melk* |
![]() |
| 12:00 - 13:00 |
Lunch |
|
![]() |
| |
Protocol
Biopsies & Subclinical Rejection
Symposium |
Robert B. Colvin
Mark Haas |
|
13:00-13:20 |
Features of protocol biopsies not yet scored in
Banff. |
Michael Mengel* |
|
13:20-13:40 |
Protocol biopsies –
overall findings on live kidney donors. |
Edward Kraus* |
|
13:40-14:00 |
Protocol biopsies in incompatible transplant
- subclinical AMR and how the
latter may affect long-term graft function. |
Mark Haas* |
|
14:00-14:20 |
Molecular markers of active rejection. |
Roslyn B. Mannon* |
|
14:20-14:40 |
The value of zero-hour implantation biopsies. |
Volker Nickeleit* |
| 14:40-15:00 |
Protocol biopsy as surrogate marker
in clinical trials. |
Daniel Seron* |
![]() |
| 15:00 - 15:30 |
Break |
|
![]() |
| 15:30-15:50 |
Glomerular disease protocol biopsies. |
Fernando Cosio* |
|
15:50 - 16:10 |
Molecular studies in protocol biopsies. |
Brian Nankivell* |
|
16:10 - 16:20 |
What should be scored in protocol biopsies with
discussion on Banff additions? |
Michael Mengel* |
![]() |
|
19:00 - 23:00 |
Gala Dinner Evening |
Pazo de Vilaboa |
![]() |
THURSDAY
28 JUNE 2007 (Day 5)
FRIDAY 29 June
2007 (Day 6)
| Time |
Topic |
Location |
| |
Reports – Consensus statements |
|
| 08:00 - 08:30 |
C4d staining |
|
| 08:30 - 09:00 |
Heart |
|
| 09:00 - 09:30 |
Pancreas allografts |
|
| 09:30 - 10:00 |
Composite tissue allografts |
|
| 10:00 - 10:30 |
Protocol biopsy findings |
|
| 10:30 - 11:00 |
Liver |
|
|
11:00 |
Adjourn |
|
|
pm |
Departure |
|
|
Scientific
Programme